These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1418888)

  • 21. Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients.
    Wong JO; Leung SP; Mak T; Ng RM; Chan KT; Hon-Kee Cheung H; Choi WK; Lai J; Wai-Kiu Tsang A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):251-64. PubMed ID: 16316716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of novel antipsychotic drugs.
    Raleigh F
    Pharmacotherapy; 1996; 16(6 Pt 2):160S-165S; discussion 166S-168S. PubMed ID: 8948000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Motor and mental side effects of clozapine.
    Gerlach J; Peacock L
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
    Alfaro J; Berdichevsky E; Conte G; Tellez C
    Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and adverse effects of clozapine in four elderly psychotic patients.
    Pitner JK; Mintzer JE; Pennypacker LC; Jackson CW
    J Clin Psychiatry; 1995 May; 56(5):180-5. PubMed ID: 7737956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suicide in schizophrenia: risk factors and clozapine treatment.
    Meltzer HY
    J Clin Psychiatry; 1998; 59 Suppl 3():15-20. PubMed ID: 9541333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clozapine: an exclusive treatment?].
    Vanelle JM
    Encephale; 1992 Sep; 18 Spec No 3():441-5. PubMed ID: 1339761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clozapine screening: white bloodcell counts no longer sufficient].
    Cohen D;
    Tijdschr Psychiatr; 2010; 52(11):785-90. PubMed ID: 21064021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on the clinical efficacy and side effects of clozapine.
    Safferman A; Lieberman JA; Kane JM; Szymanski S; Kinon B
    Schizophr Bull; 1991; 17(2):247-61. PubMed ID: 1882209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychopharmacology. Clozapine and agranulocytosis.
    Feldman J
    Psychiatr Serv; 1996 Nov; 47(11):1177-8. PubMed ID: 8916231
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clozapine in long-term treatment of schizophrenic patients].
    Meise U; Kurz M; Fleischhacker WW
    Fortschr Neurol Psychiatr; 1993 Sep; 61(9):319-25. PubMed ID: 8225153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [When to continue or stop Clozapine therapy?].
    Jalenques I; Coudert AJ
    Encephale; 1992 Sep; 18 Spec No 3():437-40. PubMed ID: 1339760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Frequent cases of agranulocytosis due to clozapin (leponex) in eastern Switzerland].
    Jungi WF; Fischer J; Senn HJ; Hartlapp J; Pöldinger W; Kunz H; Krupp P
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1861-4. PubMed ID: 929152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indications for Clozapine].
    Gaussarès C
    Encephale; 1992 Sep; 18 Spec No 3():433-6. PubMed ID: 1339759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maximizing clozapine therapy: managing side effects.
    Lieberman JA
    J Clin Psychiatry; 1998; 59 Suppl 3():38-43. PubMed ID: 9541337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopenia.
    Combs MD; Perry PJ; Bever KA
    Pharmacotherapy; 1997; 17(6):1300-4. PubMed ID: 9399615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma clozapine and desmethylclozapine levels in clozapine-induced agranulocytosis.
    Hasegawa M; Cola PA; Meltzer HY
    Neuropsychopharmacology; 1994 Aug; 11(1):45-7. PubMed ID: 7945743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.
    Fitton A; Heel RC
    Drugs; 1990 Nov; 40(5):722-47. PubMed ID: 2292234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of clozapine in treatment-refractory schizophrenia.
    Kuoppasalmi K; Rimon R; Naukkarinen H; Lang S; Sandqvist A; Leinonen E
    Schizophr Res; 1993 Jun; 10(1):29-32. PubMed ID: 8369229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.